secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001493152-26-005210
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio sees 48% Q2 revenue growth YoY, H1 revenue tops $2M
-------------------------------------------------------------------

- Fiscal Q2 2026 revenue expected up ~48% YoY; readers more than double (+104% YoY).
- H1 2026 total revenue ~$2.01M (+36% YoY); cartridge sales +38%, readers +50%.
- CEO cites expanding installed base as foundation for recurring cartridge revenue.
- Company expects to file 10-Q for Q2 ended Dec 31, 2025 during week of Feb 9, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226005210/0001493152-26-005210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226005210/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer